Matthew William Kellinger

This inventor holds 42 USPTO granted patents and 37 published patent applications, plus 4 CIPO patents and 11 EPO patents, primarily in Nucleic Acid Technologies. Top assignees: Element Biosciences, Inc., Illumina Corporation, Illumina Cambridge Limited. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthew William Kellinger. Retrieved from https://idiyas.com/inventor/matthew-william-kellinger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 42 (Patent Applications = 37)

% Patents Active = 100.0

CIPO Patents = 4 (Patent Applications = 3)

EPO Patents = 11 (Patent Applications = 26)

Average Co-Inventor Count = 5.1

ph-index = 12

Forward Citations = 342(Granted Patents)

Company Filing History:

25 out of 48

Element Biosciences, Inc.

Illumina Cambridge Limited

patents

4. 2 out of 33

Illumina Singapore Pte. Ltd.

patents

where one patent can have more than one assignee

Years Active: 2017-2026

Loading Chart...

Areas of Expertise:

Nucleic Acid Analysis

Engineered Polymerases

Sequencing Methods

Therapeutic Agents

Circular Nucleic Acids

Multivalent Binding

Polymerase Binding

Recombinase Mutants

Flow Cell Devices

Modified Polymerases

Enzyme-Linked Nucleotides

Monoclonal Clusters

42 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12559864 - Platform for discovery and analysis of therapeutic agents (2026-02-24),

2. 12492396 - METHODS FOR GENERATING CIRCULAR NUCLEIC ACID MOLECULES (2025-12-09),

3. 12391929 - Polymerase-nucleotide conjugates for sequencing by trapping (2025-08-19),

4. 12385092 - Methods and arrays for producing and sequencing monoclonal clusters of nucleic acid (2025-08-12),

5. 12365892 - Double-stranded splint adaptors with universal long splint strands and methods of use (2025-07-22),

6. 12351868 - Enzyme-linked nucleotides (2025-07-08),

7. 12331356 - Multipart reagents having increased avidity for polymerase binding (2025-06-17),

8. 12270056 - Engineered polymerases (2025-04-08),

9. 12241891 - Multivalent binding composition for nucleic acid analysis (2025-03-04),

10. 12163163 - Engineered polymerases with reduced sequence-specific errors (2024-12-10),

11. 12139727 - Engineered polymerases (2024-11-12),

12. 12134766 - Methods for generating circular nucleic acid molecules (2024-11-05),

13. 12117438 - Multivalent binding composition for nucleic acid analysis (2024-10-15),

14. 12091657 - Reverse transcriptase for nucleic acid sequencing (2024-09-17),

15. 12006518 - Engineered polymerases with reduced sequence-specific errors (2024-06-11),

Title: The Innovative Journey of Matthew William Kellinger

Introduction: Matthew William Kellinger is a renowned inventor based in San Diego, CA (US) known for his groundbreaking contributions to various industries.

Latest Patents: Matthew William Kellinger holds several patents in the fields of renewable energy, medical devices, and consumer electronics, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Matthew William Kellinger has worked with leading research institutions and companies to develop cutting-edge technologies that have revolutionized their respective fields.

Collaborations: Throughout his career, Matthew William Kellinger has collaborated with top universities, innovative startups, and established corporations to bring his inventions to life and make a lasting impact on society.

Conclusion: Matthew William Kellinger's passion for innovation and his relentless pursuit of excellence continue to drive him towards creating solutions that shape the future of technology.

Profile summary based on public USPTO records.